2020
DOI: 10.1111/bjd.19267
|View full text |Cite
|
Sign up to set email alerts
|

Reduction in skin cancer diagnosis, and overall cancer referrals, during the COVID‐19 pandemic

Abstract: DEAR EDITOR, The authors of the British Association of Dermatologists' (BAD) clinical guidelines for managing actinic keratosis 1 and the BAD's Therapy & Guidelines subcommittee wish to notify readers of the 2017 guideline publication that the marketing authorization for ingenol mebutate has been suspended by the UK's Medicines and Healthcare products Regulatory Agency (MHRA), as of 27 January 2020. 2 This is due to emerging evidence 3,4 suggesting possible links between use of the product and an increased ris… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

12
77
0
4

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(93 citation statements)
references
References 2 publications
12
77
0
4
Order By: Relevance
“…For malignant cancers, a backlog of patients with potential symptoms in the UK is expected following the COVID-19 emergency. 25 Furthermore, a 34·3% reduction in the number of urgent referrals for diagnosis in the UK was reported between February and April, 2020, 7 with Lai and colleagues reporting a reduction of 70–89% for the same time period. 8 We observed a modest, non-significant, reduction (16·0%) in the number of malignant cancer diagnoses between March 1 and May 31, 2020.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…For malignant cancers, a backlog of patients with potential symptoms in the UK is expected following the COVID-19 emergency. 25 Furthermore, a 34·3% reduction in the number of urgent referrals for diagnosis in the UK was reported between February and April, 2020, 7 with Lai and colleagues reporting a reduction of 70–89% for the same time period. 8 We observed a modest, non-significant, reduction (16·0%) in the number of malignant cancer diagnoses between March 1 and May 31, 2020.…”
Section: Discussionmentioning
confidence: 99%
“…In a report from the Salford Royal NHS Foundation Trust, a reduction of 53% in skin cancer diagnoses was predicted between March and April, 2020. 7 There is a delay between the time when a patient receives a cancer diagnosis in secondary care, and the data being entered into their primary care record. 26 Therefore, the lower reduction in cancer diagnoses observed compared with the other diseases assessed could be partially explained by this time lag.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Access to healthcare generally declined in all but the most urgent circumstances, and departments have already identified a reduction in referrals and diagnoses of skin malignancies. 1 …”
mentioning
confidence: 99%
“…Delay in referral of urgent skin cancers may result in patients presenting later with significantly advanced disease, requiring more extensive surgery and receiving worse outcomes overall. 4 During the COVID-19 pandemic, our plastic surgery service has received 27% (95% CI [16%,36%]) less than predicted urgent skin cancer referrals for the first 5 months of 2020. We expect a surge in the number of referred skin cancers as we enter a post-COVID recovery phase, in addition to a forecasted 12% increase for 2020/21.…”
mentioning
confidence: 99%